Trovirdine inhibits HIV-1 RT with an IC50 of 7 nM when employing heteropolymeric primer/template (oligo-DNA/ribosomal RNA)and dGTP as substrate. IC50 value: 7 nM Target: HIV-1 Trovirdine is currently in phase I clinical trials for potential use in thetreatment of AIDS.
Molecular Weight:
337.24
Purity:
99.43
CAS Number:
[149488-17-5]
Formula:
C13H13BrN4S
Target:
HIV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted